UNSPSC 51312409: Tripelennamine hydrochloride

This classification denotes a histamine-1 receptor antagonist with the molecular formula C16H21N3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FWV8GJ56ZN, chemically known as 1,2-ethanediamine, n, n-dimethyl-n- (phenylmethyl)-n-2-pyridinyl-, monohydrochloride but more generally known as tripelennamine hydrochloride, which bears US NIH Compound Identifier 5587. European Medicines Agency schedules Tripelennamine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04981MIG.

UNSPSC 51312409 Tripelennamine hydrochloride is a Commodity code with little relevant recent activity. The three most recent state and local contract opportunities tagged under this code involve naloxone procurement, direct-to-manufacturer prescription programs, and multi-source generic pharmaceuticals—none of which are tripelennamine hydrochloride or clearly related to it. State and local procurement systems appear to have misclassified these opportunities under the code, suggesting minimal or no active buying of tripelennamine hydrochloride itself through state and local channels at this time.

When opportunities do touch pharmaceutical procurement under broader code families, issuing bodies include individual counties (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance, serving Minnesota and Oregon). The geographic spread is wide but sparse: the few relevant opportunities span Florida, Texas, and the upper Midwest. No recent opportunities specifically solicit tripelennamine hydrochloride as a line item or named product, and no vendor data or award history is available to establish patterns of buyer preference or incumbent positions. Given the mismatch between the code's stated product and recent activity, pursuit of this code warrants verification through direct outreach to state and local health departments, correctional systems, and emergency management agencies that might stock the drug, rather than reliance on published procurement records under this classification.